Patent ID: 7569590

Claim:
A method for treating obesity, comprising: administering a therapeutically effective amount of at least one DGAT-1 inhibitor compound, or a pharmaceutically acceptable salt or a stereoisomer thereof, to a patient in need of a treatment for obesity, wherein the at least one DGAT-1 inhibitor compound is a compound of Formula I; wherein Z is selected from the group consisting of aryl and heteroaryl, wherein each aryl and heteroaryl may be optionally substituted with 1 to 3 R 5 ; R 1 , R 2 , R 3 and R 4 are independently selected from the group consisting of alkyl and alkoxy, wherein R 3 and R 4 may be taken together to form an aryl ring that is optionally substituted with 1 to 3 R 6 ; R 5 is selected from the group consisting of alkyl, thioalkyl and halo; and R 6 is selected from the group consisting of alkyl and alkoxy.